Cargando…
Reply to “Benralizumab: A potential tailored treatment for life-threatening DRESS in the COVID-19 era”
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Academy of Allergy, Asthma & Immunology
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299284/ https://www.ncbi.nlm.nih.gov/pubmed/34273580 http://dx.doi.org/10.1016/j.jaip.2021.06.048 |
| _version_ | 1783726239341608960 |
|---|---|
| author | Lang, Claudia Cécile Valérie Schmid-Grendelmeier, Peter Maverakis, Emanual Brüggen, Marie-Charlotte |
| author_facet | Lang, Claudia Cécile Valérie Schmid-Grendelmeier, Peter Maverakis, Emanual Brüggen, Marie-Charlotte |
| author_sort | Lang, Claudia Cécile Valérie |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8299284 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | American Academy of Allergy, Asthma & Immunology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82992842021-07-23 Reply to “Benralizumab: A potential tailored treatment for life-threatening DRESS in the COVID-19 era” Lang, Claudia Cécile Valérie Schmid-Grendelmeier, Peter Maverakis, Emanual Brüggen, Marie-Charlotte J Allergy Clin Immunol Pract Correspondence and Replies American Academy of Allergy, Asthma & Immunology 2021-09 2021-07-15 /pmc/articles/PMC8299284/ /pubmed/34273580 http://dx.doi.org/10.1016/j.jaip.2021.06.048 Text en © 2021 American Academy of Allergy, Asthma & Immunology. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence and Replies Lang, Claudia Cécile Valérie Schmid-Grendelmeier, Peter Maverakis, Emanual Brüggen, Marie-Charlotte Reply to “Benralizumab: A potential tailored treatment for life-threatening DRESS in the COVID-19 era” |
| title | Reply to “Benralizumab: A potential tailored treatment for life-threatening DRESS in the COVID-19 era” |
| title_full | Reply to “Benralizumab: A potential tailored treatment for life-threatening DRESS in the COVID-19 era” |
| title_fullStr | Reply to “Benralizumab: A potential tailored treatment for life-threatening DRESS in the COVID-19 era” |
| title_full_unstemmed | Reply to “Benralizumab: A potential tailored treatment for life-threatening DRESS in the COVID-19 era” |
| title_short | Reply to “Benralizumab: A potential tailored treatment for life-threatening DRESS in the COVID-19 era” |
| title_sort | reply to “benralizumab: a potential tailored treatment for life-threatening dress in the covid-19 era” |
| topic | Correspondence and Replies |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299284/ https://www.ncbi.nlm.nih.gov/pubmed/34273580 http://dx.doi.org/10.1016/j.jaip.2021.06.048 |
| work_keys_str_mv | AT langclaudiacecilevalerie replytobenralizumabapotentialtailoredtreatmentforlifethreateningdressinthecovid19era AT schmidgrendelmeierpeter replytobenralizumabapotentialtailoredtreatmentforlifethreateningdressinthecovid19era AT maverakisemanual replytobenralizumabapotentialtailoredtreatmentforlifethreateningdressinthecovid19era AT bruggenmariecharlotte replytobenralizumabapotentialtailoredtreatmentforlifethreateningdressinthecovid19era |